Marshall Wace North America L.P. lifted its stake in shares of Curtiss-Wright Corp. (NYSE:CW) by 21.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 27,125 shares of the aerospace company’s stock after buying an additional 4,779 shares during the quarter. Marshall Wace North America L.P. owned about 0.06% of Curtiss-Wright worth $3,073,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of CW. Vanguard Group Inc grew its position in Curtiss-Wright by 0.7% in the 3rd quarter. Vanguard Group Inc now owns 3,546,418 shares of the aerospace company’s stock worth $487,349,000 after purchasing an additional 23,821 shares during the period. Comerica Bank boosted its stake in shares of Curtiss-Wright by 1.4% during the 4th quarter. Comerica Bank now owns 28,983 shares of the aerospace company’s stock worth $3,268,000 after acquiring an additional 411 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Curtiss-Wright by 11.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,113 shares of the aerospace company’s stock worth $216,000 after acquiring an additional 210 shares during the last quarter. Virginia Retirement Systems ET AL boosted its stake in shares of Curtiss-Wright by 2.7% during the 4th quarter. Virginia Retirement Systems ET AL now owns 7,500 shares of the aerospace company’s stock worth $766,000 after acquiring an additional 200 shares during the last quarter. Finally, California Public Employees Retirement System boosted its stake in shares of Curtiss-Wright by 0.7% during the 4th quarter. California Public Employees Retirement System now owns 109,522 shares of the aerospace company’s stock worth $11,184,000 after acquiring an additional 747 shares during the last quarter. Institutional investors and hedge funds own 76.42% of the company’s stock.
CW has been the topic of a number of analyst reports. ValuEngine upgraded shares of Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, May 17th. Zacks Investment Research cut shares of HEXO from a “hold” rating to a “sell” rating in a research note on Wednesday, May 15th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $135.17.
NYSE CW traded up $1.96 on Friday, reaching $127.12. The company had a trading volume of 310,958 shares, compared to its average volume of 291,415. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.05 and a quick ratio of 1.31. The stock has a market cap of $5.35 billion, a PE ratio of 19.96, a PEG ratio of 2.51 and a beta of 1.23. The stock’s 50 day moving average is $119.79. Curtiss-Wright Corp. has a 12 month low of $95.23 and a 12 month high of $141.29.
Curtiss-Wright (NYSE:CW) last announced its quarterly earnings results on Wednesday, May 8th. The aerospace company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.14. The company had revenue of $578.30 million for the quarter, compared to the consensus estimate of $574.76 million. Curtiss-Wright had a net margin of 11.78% and a return on equity of 18.68%. Curtiss-Wright’s revenue for the quarter was up 5.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.98 EPS. Equities research analysts expect that Curtiss-Wright Corp. will post 7.13 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, July 5th. Stockholders of record on Thursday, June 20th were issued a $0.17 dividend. The ex-dividend date was Wednesday, June 19th. This is an increase from Curtiss-Wright’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.53%. Curtiss-Wright’s payout ratio is 10.68%.
Curtiss-Wright declared that its Board of Directors has approved a stock repurchase plan on Wednesday, May 15th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the aerospace company to purchase up to 4.1% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.
Curtiss-Wright Company Profile
Curtiss-Wright Corporation, together with its subsidiaries, designs, manufactures, and overhauls precision components, and engineered products and services primarily to the aerospace, defense, general industrial, and power generation markets worldwide. The company operates through three segments: Commercial/Industrial, Defense, and Power.
Receive News & Ratings for Curtiss-Wright Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curtiss-Wright and related companies with MarketBeat.com's FREE daily email newsletter.